Morindone as a potential therapeutic compound targeting TP53 and KRAS mutations in colorectal cancer cells
There is an increasing demand for anticancer agent in treating colorectal cancer (CRC) with frequently mutated TP53 and KRAS genes. Phytochemical compounds are suitable as chemoprevention for CRC since dietary factor is a major risk factor. Anthraquinones from Morinda citrifolia L. were previously r...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Published: |
Elsevier
2024
|
| Subjects: | |
| Online Access: | http://eprints.um.edu.my/45462/ https://doi.org/10.1016/j.cbi.2024.110928 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|